Specific down regulation of 3T3-L1 adipocyte differentiation by cell-permeable antisense HIF1alpha-oligonucleotide. - Wikidata - wikimedia - TriplyDB

Specific down regulation of 3T3-L1 adipocyte differentiation by cell-permeable antisense HIF1alpha-oligonucleotide.

Specific down regulation of 3T3-L1 adipocyte differentiation by cell-permeable antisense HIF1alpha-oligonucleotide.

http://www.wikidata.org/entity/Q33823337

about

Cell permeable cocaine esterases constructed by chemical conjugation and genetic recombination.In vivo delivery of cell-permeable antisense hypoxia-inducible factor 1α oligonucleotide to adipose tissue reduces adiposity in obese mice.Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery.Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides Chemically and biologically synthesized CPP-modified gelonin for enhanced anti-tumor activity.Immobilized thermolysin for highly efficient production of low-molecular-weight protamine--an attractive cell-penetrating peptide for macromolecular drug delivery applications.Citral, a Monoterpene Inhibits Adipogenesis Through Modulation of Adipogenic Transcription Factors in 3T3-L1 Cells

P2860

Q35952119-C220DEA0-F90E-4837-95CE-D158728220A9 Q36044388-25A0369E-2684-4790-AB6A-3F0008476934 Q36854231-EED3AC67-1654-4A57-BE7D-537999E8FC99 Q37110643-43B7767C-DE6D-49B6-B27F-4C800F55F894 Q37361218-CA269091-A9BE-427E-BAD5-0C6AE98D6824 Q38469048-E9116486-3950-4E8E-9A95-522E4A96A555 Q57487028-B656F046-38B2-4E46-AC93-C08813D7564F

P2860

Specific down regulation of 3T3-L1 adipocyte differentiation by cell-permeable antisense HIF1alpha-oligonucleotide.

http://www.wikidata.org/entity/Q33823337

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Specific down regulation of 3T ...... nse HIF1alpha-oligonucleotide.

@ast

Specific down regulation of 3T ...... nse HIF1alpha-oligonucleotide.

@en

type

label

Specific down regulation of 3T ...... nse HIF1alpha-oligonucleotide.

@ast

Specific down regulation of 3T ...... nse HIF1alpha-oligonucleotide.

@en

prefLabel

Specific down regulation of 3T ...... nse HIF1alpha-oligonucleotide.

@ast

Specific down regulation of 3T ...... nse HIF1alpha-oligonucleotide.

@en

P1433

Q33823337-3C7270F9-5B05-483F-B6B3-87A06091CB71

P1476

Q33823337-66EB7EE5-40A4-4673-8EE3-E1566544567C

P2093

Q33823337-0703092E-768E-4C5E-8360-996ECB8AC30D

Q33823337-09A751B9-2673-446C-BB60-9790367F6E1D

Q33823337-1EEADE16-85F3-4C7F-817B-BB79127E2D71

Q33823337-2237E298-B5B4-4303-8A6D-96CBC57B8FF8

Q33823337-56F5DA1D-88BC-42B6-A039-DA5F233483B3

Q33823337-6A7BB4D9-30D7-4063-956A-117D08A01636

Q33823337-732DA5FE-FC3B-43E4-98EB-8602DD3FE335

Q33823337-F65206B6-0038-4DCD-B548-1D55027DD790

P2860

Q33823337-0750B8B6-7DA5-47FA-AE06-A35582457E66

Q33823337-0CDAB214-CBD9-40DA-A623-CA0ADA8553A4

Q33823337-11AEBAF4-4282-4BA8-81F5-A6566467A5A9

Q33823337-155B7820-C185-4772-932A-8D8E55E5C5B4

Q33823337-2773EE69-6254-4D46-B714-1A02022D48C0

Q33823337-396ECF37-5E92-4B5F-9F5D-84FFCE77CC78

Q33823337-3C3DA1A0-E223-4D21-9A5D-B7742D795D90

Q33823337-437F1968-7664-4910-90DF-F79331532B8F

Q33823337-474F222C-91F2-4048-962C-41B56C676818

Q33823337-493BA75B-3C08-42A8-BB20-E9A301C90CFC

P304

Q33823337-02DEFA29-DE99-4341-92E8-1C3CDC2996B3

P31

Q33823337-941FDC21-D0C9-4625-A636-CC05739460B2

P356

Q33823337-EB6F411E-429A-4802-9DBF-4EB78CFDC119

P407

Q33823337-6367E169-1426-4717-8519-8CD2ECA718BC

P433

Q33823337-E6B5BB8D-82AC-47DD-804C-41C57AB6225C

P478

Q33823337-B74A9917-2033-486A-9EF2-447CEB8A048D

P577

Q33823337-210BAE5F-9BCE-4709-AB00-3C7DF6B63BD4

P5875

Q33823337-A3F0538D-F221-426B-BA57-02670B9CE7BC

P698

Q33823337-4B8BF7E3-7E43-4DC7-890A-F677434D0B8D

P932

Q33823337-A8B89FE5-68CA-4D04-9C7A-4245B2E2544D

P356

J.JCONREL.2010.01.026

P1433

Journal of Controlled Release

P1476

Specific down regulation of 3T ...... nse HIF1alpha-oligonucleotide.

@en

P2093

Allan E David

http://www.w3.org/2001/XMLSchema#string

Hee Sun Chung

http://www.w3.org/2001/XMLSchema#string

Huining He

http://www.w3.org/2001/XMLSchema#string

Lindsay White

http://www.w3.org/2001/XMLSchema#string

Victor C Yang

http://www.w3.org/2001/XMLSchema#string

Yongzhuo Huang

http://www.w3.org/2001/XMLSchema#string

Yoon Jeong Park

http://www.w3.org/2001/XMLSchema#string

Yoon Shin Park

http://www.w3.org/2001/XMLSchema#string

P2860

HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma.

Controlled delivery of anti-sense oligodeoxynucleotide from multilayered biocompatible phosphorylcholine polymer films.

Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents.

Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides.

Cell-penetrating peptides.

Delivery systems for antisense oligonucleotides.

Tissue oxygenation in obese and non-obese patients during laparoscopy.

P304

82-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCONREL.2010.01.026

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

144

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41172830

http://www.w3.org/2001/XMLSchema#string

P698

20109509

http://www.w3.org/2001/XMLSchema#string

P932

2862791

http://www.w3.org/2001/XMLSchema#string